Advanced Treatments & Technologies
First Successful Laser Interstitial Thermal The...
On August 11, Beijing Tiantan Puhua Hospital achieved a significant milestone by performing its first Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) to treat drug-resistant epilepsy. This minimally invasive procedure...
First Successful Laser Interstitial Thermal The...
On August 11, Beijing Tiantan Puhua Hospital achieved a significant milestone by performing its first Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) to treat drug-resistant epilepsy. This minimally invasive procedure...
Pioneering Non-Invasive Uterine Fibroid Treatme...
Beijing Tiantan Puhua Hospital has successfully performed its first Magnetic Resonance-guided Focused Ultrasound (MRgFUS) procedure for uterine fibroids, marking a significant advancement in non-invasive gynecological treatments. This innovative approach offers...
Pioneering Non-Invasive Uterine Fibroid Treatme...
Beijing Tiantan Puhua Hospital has successfully performed its first Magnetic Resonance-guided Focused Ultrasound (MRgFUS) procedure for uterine fibroids, marking a significant advancement in non-invasive gynecological treatments. This innovative approach offers...
Dr. Xian Zhang’s Latest Research on BCMA CAR-T ...
Dr. Xian Zhang's team at Ludaobei Hospital has made significant progress in the treatment of relapsed/refractory plasma cell myeloma (R/R MM). Their latest clinical study, published in Blood Advances, showcases...
Dr. Xian Zhang’s Latest Research on BCMA CAR-T ...
Dr. Xian Zhang's team at Ludaobei Hospital has made significant progress in the treatment of relapsed/refractory plasma cell myeloma (R/R MM). Their latest clinical study, published in Blood Advances, showcases...
Dr. Xingyu Cao: CD7 CAR-T Combined with Allogen...
Dr. Xingyu Cao’s groundbreaking research shows that CD7 CAR-T therapy combined with allo-HSCT significantly improves long-term survival in patients with relapsed/refractory T-ALL and T-LBL. The study, published in BJH, highlights...
Dr. Xingyu Cao: CD7 CAR-T Combined with Allogen...
Dr. Xingyu Cao’s groundbreaking research shows that CD7 CAR-T therapy combined with allo-HSCT significantly improves long-term survival in patients with relapsed/refractory T-ALL and T-LBL. The study, published in BJH, highlights...
Over 10,000 Hematopoietic Stem Cell Transplants...
On April 19, 2024, Ludaopei Hospital achieved a remarkable milestone by performing its 10,000th hematopoietic stem cell transplant. This achievement highlights the hospital's role as a leader in stem cell...
Over 10,000 Hematopoietic Stem Cell Transplants...
On April 19, 2024, Ludaopei Hospital achieved a remarkable milestone by performing its 10,000th hematopoietic stem cell transplant. This achievement highlights the hospital's role as a leader in stem cell...